<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">psychiatry</journal-id><journal-title-group><journal-title xml:lang="ru">ПСИХИАТРИЯ</journal-title><trans-title-group xml:lang="en"><trans-title>Psychiatry (Moscow) (Psikhiatriya)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1683-8319</issn><issn pub-type="epub">2618-6667</issn><publisher><publisher-name>FSBSI “The Mental Health Research Centre”;   LLC «Publisher «MIA»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.30629/2618-6667-2023-21-2-28-37</article-id><article-id custom-type="elpub" pub-id-type="custom">psychiatry-952</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ПСИХОПАТОЛОГИЯ, КЛИНИЧЕСКАЯ И БИОЛОГИЧЕСКАЯ ПСИХИАТРИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PSYCHOPATHOLOGY, CLINICAL AND BIOLOGICAL PSYCHIATRY</subject></subj-group></article-categories><title-group><article-title>Взаимосвязи клинических, нейрофизиологических и нейроиммунологических показателей у больных депрессией, перенесших COVID-19</article-title><trans-title-group xml:lang="en"><trans-title>Interrelations of Clinical, Neurophysiological and Neuroimmunological Parameters in Depressive Patients after COVID-19</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3687-4319</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Изнак</surname><given-names>А. Ф.</given-names></name><name name-style="western" xml:lang="en"><surname>Iznak</surname><given-names>A. F.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Андрей Федорович Изнак, доктор биологических наук, профессор, заведующий лабораторией, лаборатория нейрофизиологии</p><p>Москва</p></bio><bio xml:lang="en"><p>Andrey F. Iznak, Dr. of Sci. (Biol.), Professor, Head of Laboratory, Laboratory of Neurophysiology</p><p>Moscow</p></bio><email xlink:type="simple">iznak@inbox.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1445-863X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Изнак</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Iznak</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Екатерина Вячеславовна Изнак, кандидат биологических наук, ведущий научный сотрудник, лаборатория нейрофизиологии</p><p>Москва</p></bio><bio xml:lang="en"><p>Ekaterina V. Iznak, Cand. of Sci. (Biol.), Leading Researcher, Laboratory of Neurophysiology</p><p>Moscow</p></bio><email xlink:type="simple">iznakekaterina@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5390-6007</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зозуля</surname><given-names>С. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Zozulya</surname><given-names>S. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Светлана Александровна Зозуля, кандидат биологических наук, ведущий научный сотрудник, лаборатория нейроиммунологии</p><p>Москва</p></bio><bio xml:lang="en"><p>Svetlana A. Zozulya, Cand. of Sci. (Biol.), Leading Researcher, Laboratory of Neuroimmunology</p><p>Moscow</p></bio><email xlink:type="simple">s.ermakova@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0400-7096</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Дамянович</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Damyanovich</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Елена Владиславовна Дамянович, кандидат медицинских наук, старший научный сотрудник, лаборатория нейрофизиологии</p><p>Москва</p></bio><bio xml:lang="en"><p>Elena V. Damyanovich, Cand. of Sci. (Med.), Senior Researcher, Laboratory of Neurophysiology</p><p>Moscow</p></bio><email xlink:type="simple">damjanov@iitp.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8344-0620</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Олейчик</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Oleichik</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Игорь Валентинович Олейчик, доктор медицинских наук, главный научный сотрудник, отдел эндогенных психических заболеваний и аффективных состояний</p><p> Москва</p></bio><bio xml:lang="en"><p>Igor V. Oleichik, Dr. of Sci. (Med.), Chief Researcher, Department of Endogenous Mental Disorders and Affective Conditions</p><p>Moscow</p></bio><email xlink:type="simple">i.oleichik@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">ФГБНУ «Научный центр психического здоровья»<country>Россия</country></aff><aff xml:lang="en">FSBSI “Mental Health Research Centre”<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>06</day><month>05</month><year>2023</year></pub-date><volume>21</volume><issue>2</issue><fpage>28</fpage><lpage>37</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Изнак А.Ф., Изнак Е.В., Зозуля С.А., Дамянович Е.В., Олейчик И.В., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Изнак А.Ф., Изнак Е.В., Зозуля С.А., Дамянович Е.В., Олейчик И.В.</copyright-holder><copyright-holder xml:lang="en">Iznak A.F., Iznak E.V., Zozulya S.A., Damyanovich E.V., Oleichik I.V.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.journalpsychiatry.com/jour/article/view/952">https://www.journalpsychiatry.com/jour/article/view/952</self-uri><abstract><p>Цель исследования: оценка влияния перенесенного заболевания коронавирусной инфекцией на клинические, нейрофизиологические, нейроиммунологические показатели и их взаимосвязи у пациенток молодого возраста, больных депрессией. Пациенты: проведен сравнительный анализ количественных клинических (по шкале HDRS-17), нейрофизиологических (ЭЭГ) и нейроиммунологических (по технологии «Нейро-иммуно-тест») показателей у двух групп больных депрессией женщин в возрасте 16–25 лет. Первая группа включала 46 пациенток, переболевших коронавирусной инфекцией в легкой или бессимптомной форме (группа «COVID»). Во вторую группу вошли 40 больных, проходивших лечение до начала пандемии (т.е. не болевших COVID-19 — группа «до COVID») и соответствующих больным первой группы по полу, возрасту, диагнозам и синдромальной структуре расстройств. У всех больных до начала курса терапии регистрировали многоканальную ЭЭГ с измерением абсолютной спектральной мощности и определяли нейроиммунологические показатели в плазме крови. Методы: клинико-психопатологический, психометрический, нейрофизиологический, нейроиммунологический, статистический. Результаты: в группе «COVID» по сравнению с группой пациенток, не болевших коронавирусной инфекцией, отмечено достоверно большее число баллов кластера соматических расстройств шкалы Гамильтона (HDRS-17), а также повышенное содержание медленноволновой ЭЭГ-активности (поддиапазонов дельта и тета-2). Средние значения нейроиммунологических показателей в двух группах статистически не различались, но значения маркеров нейропластичности (уровня аутоантител к белку S100b и к основному белку миелина) в группе «до COVID» положительно коррелировали со значениями спектральной мощности основного ритма ЭЭГ (поддиапазонов альфа-2 и альфа-3), а в группе «COVID» — со значениями спектральной мощности медленноволновой ЭЭГ-активности, отражающей сниженное функциональное состояние головного мозга. Заключение: полученные результаты свидетельствуют о том, что заболевание коронавирусной инфекцией, даже перенесенное в легкой или бессимптомной форме, оказывает влияние на клинические, нейрофизиологические, нейроиммунологические показатели и их взаимосвязи у больных депрессией пациенток молодого возраста. </p></abstract><trans-abstract xml:lang="en"><p>The aim of the study was to assess the impact of the coronavirus infection on clinical, neurophysiological and neuroimmunological parameters, as well as on their interrelations in young female depressive patients. Patients: a comparative analysis of quantitative clinical (according to the HDRS-17 scale), neurophysiological (EEG) and neuroimmunological (according to the “Neuro-immuno-test” technology) parameters was carried out in two groups of female depressive patients aged 16–25 years. The ﬁrst group included 46 patients who recovered from a mild or asymptomatic coronavirus infection (“COVID” group). The second group included 40 patients who were studied and treated before the start of the pandemic (i.e., those who did not have COVID — the “pre-COVID” group) and corresponding to patients of the ﬁrst group by gender, age, diagnoses, and syndrome structure of disorders. In all patients, prior to the start of the course of therapy, a multichannel EEG was recorded with the measurement of absolute spectral power and neuroimmunological parameters in blood plasma were determined. Methods: clinicalpsychopathological, psychometric, neurophysiological, neuroimmunological, statistical. Results: signiﬁcantly greater scores of somatic disorders cluster of HDRS-17 scale, and increased amount of slow-wave EEG activity (of delta, theta1 and theta2 subbands) were revealed in the “COVID” group in comparison to patients of “pre-COVID” group. Mean values of neuroimmunological parameters were not differed statistically between two groups, but the values of neuroplasticity markers (levels of autoantibodies to the S100b protein and to the basic myelin protein) in the “pre-COVID” group correlated positively with the spectral power values of the main EEG rhythm (alpha2 and alpha3 sub-bands), and in “COVID” group — with the values of the spectral power of slow-wave EEG activity, reﬂecting a reduced brain functional state. Conclusion: the results obtained indicate that coronavirus infection, even in mild or asymptomatic forms, affects the clinical, neurophysiological and neuroimmunological parameters, as well as their interrelations in young female depressive patients.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>COVID-19</kwd><kwd>депрессия</kwd><kwd>количественная ЭЭГ</kwd><kwd>нейроиммунология</kwd></kwd-group><kwd-group xml:lang="en"><kwd>COVID-19</kwd><kwd>depression</kwd><kwd>quantitative EEG</kwd><kwd>neuroimmunology</kwd></kwd-group><funding-group xml:lang="ru"><funding-statement>Исследование поддержано Российским научным фондом (проект РНФ № 21-18-00129 «Влия- ние комплекса социальных стрессогенных факторов, связанных с пандемией COVID-19, на психическое, психологическое и психофизиологическое состояние больных депрессией»).</funding-statement></funding-group><funding-group xml:lang="en"><funding-statement>the study supported by Russian Scientiﬁc Foundation (project No. 21-18-00129 “The impact of complex of social stress factors associated with the COVID-19 pandemic on mental, psychological and psychophysiological state of depressive patients”).</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Гусев ЕИ, Мартынов МЮ, Бойко АН, Вознюк ИА, Лащ НЮ, Сиверцева СА, Спирин НН, Шамалов НА. Новая коронавирусная инфекция (COVID-19) и поражение нервной системы: механизмы неврологических расстройств, клинические проявления, организация неврологической помощи. Журнал неврологии и психиатрии имени С.С. Корсакова. 2020;120(6):7–16. doi: 10.17116/jnevro20201200617</mixed-citation><mixed-citation xml:lang="en">Gusev EI, Martynov MYu, Boyko AN, Voznyuk IA, Latsh NYu, Sivertseva SA, Spirin NN, Shamalov NA. Novel coronavirus infection (COVID-19) and nervous system involvement: pathogenesis, clinical manifestations, organization of neurological care. S.S. Korsakov Journal of Neurology and Psychiatry/ Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2020;120(6):7–16. (In Russ.). doi: 10.17116/jnevro20201200617</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Мосолов СН. Проблемы психического здоровья в условиях пандемии COVID-19. Журнал неврологии и психиатрии имени С.С. Корсакова. 2020;120(5):7–15. doi: 10.17116/jnevro20201200517</mixed-citation><mixed-citation xml:lang="en">Mosolov SN. Problems of mental health in the situation of COVID-19 pandemic. S.S. Korsakov Journal of Neurology and Psychiatry/Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2020;120(5):7–15. (In Russ.). doi: 10.17116/jnevro20201200517</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Asadi-Pooya AA, Simani L. Central nervous system manifestations of COVID-19: A systematic review. J Neurol Sci. 2020;413:116832. doi: 10.1016/j.jns.2020.116832</mixed-citation><mixed-citation xml:lang="en">Asadi-Pooya AA, Simani L. Central nervous system manifestations of COVID-19: A systematic review. J Neurol Sci. 2020;413:116832. doi: 10.1016/j.jns.2020.116832</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Мосолов СН. Длительные психические нарушения после перенесенной острой коронавирусной инфекции SARS-CoV-2. Современная терапия психических расстройств. 2021;3:2–23. doi: 10.21265/ PSYPH.2021.31.25.001</mixed-citation><mixed-citation xml:lang="en">Mosolov SN. Long-term psychiatric sequelae of SARSCoV-2 infection. Sovremennaya terapiya psihicheskih rasstrojstv. 2021;3:2–23. (In Russ.). doi: 10.21265/ PSYPH.2021.31.25.001</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Holmes EA, O’Connor RC, Perry VH, Tracey I, Wessely S, Arseneault L, Ballard C, Christensen H, Cohen Silver R, Everall I, Ford T, John A, Kabir T, King K, Madan I, Michie S, Przybylski AK, Shafran R, Sweeney A, Worthman CM, Yardley L, Cowan K, Cope C, Hotopf M, Bullmore E. Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science. Lancet Psychiatry. 2020;7(6):547–560. doi: 10.1016/S22150366(20)30168-1 Epub 2020 Apr 15. PMID: 32304649; PMCID: PMC7159850.</mixed-citation><mixed-citation xml:lang="en">Holmes EA, O’Connor RC, Perry VH, Tracey I, Wessely S, Arseneault L, Ballard C, Christensen H, Cohen Silver R, Everall I, Ford T, John A, Kabir T, King K, Madan I, Michie S, Przybylski AK, Shafran R, Sweeney A, Worthman CM, Yardley L, Cowan K, Cope C, Hotopf M, Bullmore E. Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science. Lancet Psychiatry. 2020;7(6):547–560. doi: 10.1016/S22150366(20)30168-1 Epub 2020 Apr 15. PMID: 32304649; PMCID: PMC7159850.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Sher L. The impact of the COVID-19 pandemic on suicide rates. QJM. 2020;113(10):707–712. doi: 10.1093/qjmed/hcaa202</mixed-citation><mixed-citation xml:lang="en">Sher L. The impact of the COVID-19 pandemic on suicide rates. QJM. 2020;113(10):707–712. doi: 10.1093/qjmed/hcaa202</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Ferrando SJ, Klepacz L, Lynch S, Tavakkoli M, Dornbush R, Baharani R, Smolin Y, Bartell A. COVID-19 psychosis: A potential new neuropsychiatric condition triggered by novel coronavirus infection and the inflammatory response? Psychosomatics. 2020;61(5):551–555. doi: 10.1016/j. psym.2020.05.012</mixed-citation><mixed-citation xml:lang="en">Ferrando SJ, Klepacz L, Lynch S, Tavakkoli M, Dornbush R, Baharani R, Smolin Y, Bartell A. COVID-19 psychosis: A potential new neuropsychiatric condition triggered by novel coronavirus infection and the inflammatory response? Psychosomatics. 2020;61(5):551–555. doi: 10.1016/j. psym.2020.05.012</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Олейчик ИВ, Баранов ПА, Сизов СВ, Морева АС, Хоанг СЗ. Клинико-психопатологические особенности эндогенных депрессивно-бредовых состояний, развившихся в различные сроки после перенесенной коронавирусной инфекции. Со- временная терапия в психиатрии и неврологии. 2022;1–2:9–13.</mixed-citation><mixed-citation xml:lang="en">Oleichik IV, Baranov PA, Sizov SV, Moreva AS, Hoang SZ. Clinical and psychopathological features of endogenous depressive-delusional states developing in different time after COVID-19 recovery. Sovremennaya terapiya v psihiatrii i nevrologii. 2022;1–2:9–13. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Pastor J, Vega-Zelaya L, Martin Abad E. Speciﬁc EEG encephalopathy pattern in SARS-CoV-2 patients. J Clin Med. 2020;9(5):1545. doi: 10.3390/jcm9051545</mixed-citation><mixed-citation xml:lang="en">Pastor J, Vega-Zelaya L, Martin Abad E. Speciﬁc EEG encephalopathy pattern in SARS-CoV-2 patients. J Clin Med. 2020;9(5):1545. doi: 10.3390/jcm9051545</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Petrescu A-M, Taussig D, Bouilleret V. Electroencephalogram (EEG) in COVID-19: a systematic retrospective study. Neurophysiol Clin. 2020;50(3):155–165. doi: 10.1016/j.neucli.2020.06.001</mixed-citation><mixed-citation xml:lang="en">Petrescu A-M, Taussig D, Bouilleret V. Electroencephalogram (EEG) in COVID-19: a systematic retrospective study. Neurophysiol Clin. 2020;50(3):155–165. doi: 10.1016/j.neucli.2020.06.001</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Vellieux G, Rouvel-Tallec A, Jaquet P, Grinea A. Sonneville R, d’Ortho M-P. COVID-19 associated encephalopathy: is there a speciﬁc EEG pattern? Clin Neurophysiol 2020;131(8):1928–1930. doi: 10.1016/j. clinph.2020.06.005</mixed-citation><mixed-citation xml:lang="en">Vellieux G, Rouvel-Tallec A, Jaquet P, Grinea A. Sonneville R, d’Ortho M-P. COVID-19 associated encephalopathy: is there a speciﬁc EEG pattern? Clin Neurophysiol 2020;131(8):1928–1930. doi: 10.1016/j. clinph.2020.06.005</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Sáez-Landete I, Gómez-Domínguez A, Estrella-León B, Díaz-Cid A, Fedirchyk O, Escribano-Muñoz M, Pedrera-Mazarro A, Martín-Palomeque G, Garcia-Ribas G, Rodríguez-Jorge F, Santos-Pérez G, Lourido-García D, Regidor-BaillyBailliere I. Retrospective Analysis of EEG in Patients with COVID-19: EEG Recording in Acute and Follow-up Phases. Clinical EEG and Neuroscience. 2022;53(3):215–228. doi: 10.1177/15500594211035923</mixed-citation><mixed-citation xml:lang="en">Sáez-Landete I, Gómez-Domínguez A, Estrella-León B, Díaz-Cid A, Fedirchyk O, Escribano-Muñoz M, Pedrera-Mazarro A, Martín-Palomeque G, Garcia-Ribas G, Rodríguez-Jorge F, Santos-Pérez G, Lourido-García D, Regidor-BaillyBailliere I. Retrospective Analysis of EEG in Patients with COVID-19: EEG Recording in Acute and Follow-up Phases. Clinical EEG and Neuroscience. 2022;53(3):215–228. doi: 10.1177/15500594211035923</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Клюшник ТП, Смулевич АБ, Зозуля СА, Воронова ЕИ. Нейробиология шизофрении и клинико-психопатологические корреляты (к построению клинико-биологической модели). Психиатрия. 2021;19(1):6–15. doi: 10.30629/2618-6667-2021-191-6-15.</mixed-citation><mixed-citation xml:lang="en">Klyushnik TP, Smulevich AB, Zozulya SA, Voronova EI. Neurobiology of schizophrenia (to the construction of clinical and biological model). Psychiatry (Moscow) (Psikhiatriya). 2021;19(1):6–15. (In Russ.). doi: 10.30629/2618-6667-2021-19-1-6-15</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Lee CH, Giuliani F. The Role of Inﬂammation in Depression and Fatigue. Front Immunol. 2019;10:1696. doi: 10.3389/fimmu.2019.01696 PMID: 31379879; PMCID: PMC6658985.</mixed-citation><mixed-citation xml:lang="en">Lee CH, Giuliani F. The Role of Inﬂammation in Depression and Fatigue. Front Immunol. 2019;10:1696. doi: 10.3389/fimmu.2019.01696 PMID: 31379879; PMCID: PMC6658985.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Beurel L, Toups M, Nemeroff CB. The Bidirectional Relationship of Depression and Inflammation: Double Trouble. Neuron. 2020;107(2):234–256. doi: 10.1016/j.neuron.2020.06.002</mixed-citation><mixed-citation xml:lang="en">Beurel L, Toups M, Nemeroff CB. The Bidirectional Relationship of Depression and Inflammation: Double Trouble. Neuron. 2020;107(2):234–256. doi: 10.1016/j.neuron.2020.06.002</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Yea Z, Kappelmannb N, Moserb S, Smithd GD, Burgess S, Jonesa PB, Khandakera GM. Role of inﬂammation in depression and anxiety: Tests for disorder speciﬁcity, linearity and potential causality of association in the UK Biobank. EClinicalMedicine. 2021;38:100992. doi: 10.1016/j.eclinm.2021.100992</mixed-citation><mixed-citation xml:lang="en">Yea Z, Kappelmannb N, Moserb S, Smithd GD, Burgess S, Jonesa PB, Khandakera GM. Role of inﬂammation in depression and anxiety: Tests for disorder speciﬁcity, linearity and potential causality of association in the UK Biobank. EClinicalMedicine. 2021;38:100992. doi: 10.1016/j.eclinm.2021.100992</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Зозуля СА, Сизов СВ, Олейчик ИВ, Клюшник ТП. Клинико-иммунологические корреляты при эндогенных психозах, развившихся после перенесенного COVID-19. Журнал неврологии и психиатрии имени С.С. Корсакова. 2022;122(6, вып. 2):71–77. doi: 10.17116/jnevro202212206271</mixed-citation><mixed-citation xml:lang="en">Zozulya SA, Sizov SV, Oleichik IV, Klyushnik TP. Clinical and immunological correlates in endogenous psychoses developed after COVID-19. S.S. Korsakov Journal of Neurology and Psychiatry/Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2022;122(6 vyp. 2):71–77. (In Russ.). doi: 10.17116/jnevro202212206271</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Изнак ЕВ, Изнак АФ, Олейчик ИВ, Зозуля СА. Клинико-нейробиологические корреляции у пациенток юношеского возраста с несуицидальным самоповреждающим поведением. Физиология человека. 2021;47(6):18–24. doi: 10.31857/ S0131164621050052</mixed-citation><mixed-citation xml:lang="en">Iznak EV, Iznak AF, Oleichik IV, Zozulya SA. Clinical-Neurobiological Correlations in Female Adolescents with Non-Suicidal Self-Injurious Behavior. Human Physiology. 2021;47(6):18–24. (In Russ.). doi: 10.31857/S0131164621050052</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Hamilton M. Hamilton Rating Scale for Depression (Ham-D). Handbook of Psychiatric Measures. Washington, DC: American Psychiatric Association, 2000:526–529.</mixed-citation><mixed-citation xml:lang="en">Hamilton M. Hamilton Rating Scale for Depression (Ham-D). Handbook of Psychiatric Measures. Washington, DC: American Psychiatric Association, 2000:526–529.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Митрофанов АА. Компьютерная система анализа и топографического картирования электрической активности мозга с нейрометрическим банком ЭЭГ-данных (описание и применение). М., 2005.</mixed-citation><mixed-citation xml:lang="en">Mitrofanov AA. Computer system for analysis and topographic mapping of brain electrical activity with a neurometric bank of EEG data (description and application). M. 2005. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Клюшник ТП, Зозуля СА, Андросова ЛВ, Сарманова ЗВ, Отман ИН, Пантелеева ГП, Олейчик ИВ, Копейко ГИ, Борисова ОА, Абрамова ЛИ, Бологов ПВ, Столяров СА. Лабораторная диагностика в мониторинге пациентов с эндогенными психозами («Нейро-иммуно-тест»). Медицинская технология. М.: МИА, 2014.</mixed-citation><mixed-citation xml:lang="en">Klyushnik TP, Zozulya SA, Androsova LV, Sarmanova ZV, Otman IN, Panteleyeva GP, Oleichik IV, Kopeiko GI, Borisova OA, Abramova LI, Bologov PV, Stolyarov SA. Laboratory Diagnostics in Monitoring of Patients with Endogenous Psychoses (“Neuro-Immuno-Test”). Medical Technology. Moscow: Medical Informational Agency, 2014. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Ludvigsson JF. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr. 2020;109(6):1088–1095. doi: 10.1111/apa.15270 Epub 2020 Apr 14. PMID: 32202343; PMCID: PMC7228328.</mixed-citation><mixed-citation xml:lang="en">Ludvigsson JF. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr. 2020;109(6):1088–1095. doi: 10.1111/apa.15270 Epub 2020 Apr 14. PMID: 32202343; PMCID: PMC7228328.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
